Recombinant Proteins
- (2)
- (970)
- (1)
- (23,544)
- (5)
- (1)
- (1)
- (67)
- (219)
- (4,426)
- (23)
- (1)
- (4)
- (2)
- (13)
- (21,464)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (71)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (254)
- (22,607)
- (1)
- (1)
- (2)
- (1)
- (13)
- (26,167)
- (266)
- (32)
- (3)
- (708)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (108)
- (1)
- (3,783)
- (1,408)
- (3)
- (4)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (14)
- (137)
- (48)
- (6)
- (17)
- (2)
- (1)
- (4)
- (82)
- (12)
- (2)
- (3)
- (80)
- (4)
- (113)
- (96)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,525)
- (2)
- (1)
- (3)
- (18)
- (48)
- (3)
- (1)
- (2)
- (9)
- (27)
- (2)
- (198)
- (1)
- (4)
- (1)
- (2)
- (114)
- (44)
- (2)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (23,710)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (1)
- (6,726)
- (6)
- (4)
- (1)
- (3)
- (1)
- (3)
- (2)
- (13)
- (17)
- (1)
- (3)
- (3)
- (4)
- (25,927)
- (240)
- (1)
- (3)
- (286)
- (2)
- (61,760)
- (1)
- (15)
- (1)
- (2)
- (45,219)
- (5,705)
- (245)
- (168)
- (56)
- (3,364)
- (2)
- (1)
- (2)
- (1)
- (21)
- (559)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (27)
- (1)
- (8)
- (15)
- (1)
- (72)
- (1)
- (1,050)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (4)
- (1)
- (1)
- (26,024)
- (5)
- (1)
- (4)
- (582)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (14)
- (32)
- (24)
- (1)
- (2)
- (16)
- (120)
- (9)
- (2)
- (1)
- (2)
- (2)
- (2)
- (23)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,575)
- (1)
- (48)
- (7)
- (1)
- (3)
- (18)
- (2)
- (62)
- (1)
- (4)
- (2)
- (9)
- (59)
- (1)
- (2)
- (3)
- (1)
- (391)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (2)
- (6)
- (19)
- (7)
- (2)
- (2)
- (3)
- (45)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (2)
- (8)
- (2)
- (3)
- (38,962)
- (1)
- (11)
Filtered Search Results
Fisher BioReagents™ Bovine Serum Albumin (BSA) DNase- and Protease-free Powder
Purified by proprietary heat shock process
Fisher BioReagents™ Bovine Serum Albumin (BSA) Protease-free Powder
Purified by a heat shock process
R&D Systems™ Recombinant Human TGF-beta 1 (Human Cell-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Gene Alias | CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1 |
| Molecular Weight (g/mol) | 12.8 kDa (monomer) |
| Gene ID (Entrez) | 7040 |
| Structural Form | Disulfide-linked homodimer |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Human embryonic kidney cell,HEK293-derived human TGF-beta 1 protein Ala279-Ser390 |
| Recombinant | Recombinant |
| Name | TGF-beta 1 |
Fisher BioReagents™ Bovine Serum Albumin (BSA) Fatty Acid-free Powder
Purified by a heat shock process with additional treatments
Gibco™ Human EGF Recombinant Protein
Recombinant Protein
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human EGF |
| Purification Method | Purified |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | EGF |
| Storage Requirements | 4°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01133 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 1950 |
| Product Line | Gibco |
R&D Systems™ Recombinant Human EGF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 6 kDa, reducing conditions; M.W. (theoretical): 6 kDa |
| Gene Symbol | EGF |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | EGF |
| Source | E. coli-derived human EGF protein Asn971-Arg1023, with an N-terminal Met |
| Name | EGF |
| Accession Number | P01133 |
| Gene ID (Entrez) | 1950 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 500 μg/mL in sterile PBS. |
| Recombinant | Recombinant |
Gibco™ CTS™ Vitronectin (VTN-N) Recombinant Human Protein, truncated
Gibco™ CTS (Cell Therapy Systems) Vitronectin (VTN-N) Recombinant Human Protein provides a defined surface for feeder-free culture of human pluripotent stem cells (PSCs). When used with CTS Essential 8 Medium (A2656101), CTS Vitronectin has been proven to maintain pluripotency and normal growth characteristics in multiple PSC lines.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
R&D Systems™ Recombinant Human IL-6 Protein
A New rh IL-6 is Available! The new protein has ∼2 fold better activity and is HEK293 expressed!
Gibco™ Human IFN-gamma Recombinant Protein
Recombinant Protein
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Protein Family | Cytokines & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Liquid |
| pH Range | 7.4 |
| Common Name | IFN gamma |
| Molecular Weight (g/mol) | 16.9 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 = 0.5 - 3.0 ng/mL; determined by the dose-dependent cytostasis of human WiDr cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human IFN-gamma |
| Purification Method | Purified |
| Gene Alias | BoIFNG; cytokine; EGK_03901; gamma interferon; gamma interferon precursor; gamma-interferon; gamma-interferon precursor (AA -23 to 143); H-IFN-g; IFG; IFI; IFN gamma; IFN γ; Ifng; IFN-g; IFNG2; IFN-gamma; IFN-gamma precursor; IFN-y; IFNγ; Immune interferon; Interferon; interferon gamma; interferon gamma precursor; interferon gamma type 2; Interferon y; Interferon γ; interferon, gamma; interferon-gama; interferon-gamma; Interferon-gamma level; interferon-gamma precursor; Interferonγ; M-IFN-g; R-IFN-g |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 = 0.5 - 3.0 ng/mL; determined by the dose-dependent cytostasis of human WiDr cells. |
| Formulation | 40mM tris with no preservative; pH 7.4 |
| Classification | Carrier-Free |
| Research Category | Immunology, Signal Transduction, Stem Cell Research, Virology, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Dry Ice |
| Content And Storage | -80°C |
| Gene Symbol | IFNG |
| Sequence | QDPYVKEAEN LKKYFNAGHS DVADNGTLFL GILKNWKEES DRKIMQSQIV SFYFKLFKNF KDDQSIQKSV ETIKEDMNVK FFNSNKKKRD DFEKLTNYSV TDLNVQRKAI HELIQVMAEL SPAAKTGKRK RSQMLFQGRR ASQ |
| Storage Requirements | -80°C |
| Protein Subtype | Interferons |
| Accession Number | P01579 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 3458 |
| Product Line | Gibco |
Gibco™ Human VEGF-165 Recombinant Protein
Recombinant Protein
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | ≥95% by SDS-PAGE and HPLC |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | VEGF-165 |
| Molecular Weight (g/mol) | 40 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 6 ng/mL; determined by the dose-dependent proliferation of HUVECs. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | HEK293 cells |
| For Use With (Application) | Bioactivity |
| Name | Human VEGF-165 |
| Purification Method | Purified |
| Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 6 ng/mL; determined by the dose-dependent proliferation of HUVECs. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Oncology, Angiogenesis, Stem Cell Research, Differentiation, Inflammation |
| Specific Activity | 1.0 x 106 - 1.7 x 105 units⁄mg |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Bioassay | Proliferation of HUVECs (Human Umbilical Vein Endothelial Cells) |
| Gene Symbol | Vegfa |
| Sequence | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Storage Requirements | 4°C |
| Protein Subtype | VEGF (Vascular Endothelial Growth Factor) |
| Accession Number | P15692 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 7422 |
| Product Line | Gibco |
R&D Systems™ Recombinant Human IGF-I/IGF-1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 7.6 kDa |
| Gene ID (Entrez) | 3479 |
| Formulation | Lyophilized from a 0.2μm filtered solution in PBS. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | E. coli-derived human IGF-I/IGF-1 protein Gly49-Ala118 |
| Recombinant | Recombinant |
| Name | IGF-I/IGF-1 |
R&D Systems™ Recombinant Human TNF-alpha Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human Wnt-3a Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 75%, by SDS-PAGE with silver staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 37.4 kDa |
| Gene ID (Entrez) | 89780 |
| Source | Chinese Hamster Ovary cell line,CHO-derived human Wnt-3a protein Ser19-Lys352 |
| Recombinant | Recombinant |
| Name | Wnt-3a |
Invitrogen™ Human TNF-alpha Recombinant Protein
Recombinant Protein
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Accession Number | P01375 |
|---|---|
| Regulatory Status | RUO |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Gene ID (Entrez) | 7124 |
| Gene Symbol | Tnf |
| Source | E. coli |
| Recombinant | Recombinant |
| Name | Human TNF-alpha |
| Accession Number | P60568 |
|---|---|
| Purity or Quality Grade | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 13 kDa, under reducing conditions. |
| Gene ID (Entrez) | 3558 |
| Gene Symbol | IL2 |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-2 |
| Source | E. coli-derived human IL-2 protein Ala21-Thr153, with an N-terminal Met |
| Recombinant | Recombinant |
| Name | IL-2 |